Spots Global Cancer Trial Database for A Phase 1 Study of S-3304 in Patients With Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase 1 Study of S-3304 in Patients With Solid Tumors
Official Title: A Phase 1 Study of S-3304 in Patients With Solid Tumors
Study ID: NCT00033215
Conditions
Interventions
Study Description
Brief Summary: To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Colorado Hospital, Denver, Colorado, United States
H. Lee Moffitt Concer Center and Research Institute, Tampa, Florida, United States
Roswell Park Cancer Center, Buffalo, New York, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
